Clinical outcomes following discontinuation of metformin in patients with type 2 diabetes and advanced chronic kidney disease in Hong Kong: a territory-wide, retrospective cohort and target trial emulation studyResearch in context

Clinical outcomes following discontinuation of metformin in patients with type 2 diabetes and advanced chronic kidney disease in Hong Kong: a territory-wide, retrospective cohort and target trial emulation studyResearch in context

Summary: Background: Current labelling advises discontinuation of metformin when estimated glomerular filtration rate (eGFR) < 30 ml/min/1.73 m2 due to increased risk of lactic acidosis. However, in real-world practice, the risk-benefit ratios remain uncertain. We examined the risk associations...

Full description

Bibliographic Details
Main Authors:	Aimin Yang, Mai Shi, Hongjiang Wu, Eric SH. Lau, Johnny TK. Cheung, Xinge Zhang, Baoqi Fan, Tingting Chen, Alice PS. Kong, Andrea OY. Luk, Ronald CW. Ma, Juliana CN. Chan, Elaine Chow
Format:	Article
Language:	English
Published:	Elsevier 2024-05-01
Series:	EClinicalMedicine
Subjects:	Metformin Cardiovascular disease Mortality Therapeutics Diabetes Chronic kidney disease
Online Access:	http://www.sciencedirect.com/science/article/pii/S2589537024001470

Similar Items

Clinical outcomes following discontinuation of renin-angiotensin-system inhibitors in patients with type 2 diabetes and advanced chronic kidney disease: A prospective cohort studyResearch in context
by: Aimin Yang, et al.
Published: (2023-01-01)

Health impacts of new‐onset diabetes in women post‐gestational diabetes mellitus: Insights from Hong Kong's territory‐wide data
by: Xinge Zhang, et al.
Published: (2024-06-01)

Cardiovascular Effects of Metformin
by: B. T. Kurmanbekova, et al.
Published: (2022-03-01)

Metformin and cancer mortality
by: Lev Mikhaylovich Bershteyn
Published: (2010-09-01)

Attenuated Risk Association of End-Stage Kidney Disease with Metformin in Type 2 Diabetes with eGFR Categories 1–4
by: Aimin Yang, et al.
Published: (2022-09-01)

Efficacy of metformin targets on cardiometabolic health in the general population and non-diabetic individuals: a Mendelian randomization studyResearch in context
by: Jie Zheng, et al.
Published: (2023-10-01)

Role of microRNAs in the process of metformin treating multiple diseases
by: Ma Ningning, et al.
Published: (2021-12-01)

Metformin attenuates white matter microstructural changes in Alzheimer’s disease
by: Sahar Abbaszadeh, et al.
Published: (2024-08-01)

Comparison of Outcome of Metformin And Inositol on Hormonal Aspects in Women with Polycystic Ovaries: A Quasi-Experimental Study
by: Namra Mazhar, et al.
Published: (2024-06-01)

The molecular pathology at Work: Metformin and Variability in Glycemic Control
by: sikandar hayat khan, et al.
Published: (2024-04-01)

Effects of Metformin on Ischemia/Reperfusion Injury: New Evidence and Mechanisms
by: Estefanie Osorio-Llanes, et al.
Published: (2023-08-01)

Metformin: A Potential Therapeutic Tool for Rheumatologists
by: Teresa Salvatore, et al.
Published: (2020-09-01)

Pleiotropic Effects of Metformin in Osteoarthritis
by: Sevdalina Nikolova Lambova
Published: (2023-02-01)

The Role and Mechanism of Metformin in the Treatment of Nervous System Diseases
by: Hui Li, et al.
Published: (2024-12-01)

Effects of metformin on human gingival fibroblasts: an in vitro study
by: Nouf Alshibani, et al.
Published: (2023-05-01)

Are There Differences in Gut Microbiome in Patients with Type 2 Diabetes Treated by Metformin or Metformin and Insulin?
by: Dzięgielewska-Gęsiak S, et al.
Published: (2022-11-01)

The Effect of Metformin in Diabetic and Non-Diabetic Rats with Experimentally-Induced Chronic Kidney Disease
by: Mohammed Al Za’abi, et al.
Published: (2021-05-01)

Metformin restores cognitive dysfunction and histopathological deficits in an animal model of sporadic Alzheimer's disease
by: Saghar Rabieipoor, et al.
Published: (2023-07-01)

Role of metformin in radiotherapy and chemotherapy
by: Yasemin Benderli Cihan
Published: (2019-03-01)

Revealing the role of metformin in gastric intestinal metaplasia treatment
by: Ruoyu Hu, et al.
Published: (2024-07-01)

Effect of metformin and metformin/linagliptin on gut microbiota in patients with prediabetes
by: Yoscelina Estrella Martínez-López, et al.
Published: (2024-04-01)

Metformin in the treatment of colorectal cancer and neuroendocrine tumours
by: Karolina Daniłowska, et al.
Published: (2024-08-01)

Metformin: A Narrative Review of Its Potential Benefits for Cardiovascular Disease, Cancer and Dementia
by: Wiebe M. C. Top, et al.
Published: (2022-03-01)

Unveiling the potential pleiotropic effects of metformin in treating COVID-19: a comprehensive review
by: Pavlo Petakh, et al.
Published: (2023-10-01)

Metformin and risk of gingival/periodontal diseases in diabetes patients: A retrospective cohort study
by: Chin-Hsiao Tseng, et al.
Published: (2022-10-01)

Enhancing Diabetes Treatment: Comparing Pioglitazone/Metformin with Dapagliflozin Versus Basal Insulin/Metformin in Type 2 Diabetes
by: Lin Y, et al.
Published: (2025-03-01)

Severe Metformin poisoning; Experience at a tertiary care hospital in Sri Lanka: a case series
by: P. W. M. S. S. Sirisena, et al.
Published: (2022-08-01)

Diverse Applications of the Anti-Diabetic Drug Metformin in Treating Human Disease
by: Chris-Tiann Roberts, et al.
Published: (2024-11-01)

Associations of comorbid depression with cardiovascular-renal events and all-cause mortality accounting for patient reported outcomes in individuals with type 2 diabetes: a 6-year prospective analysis of the Hong Kong Diabetes Register
by: Yiu-Lam Yeung, et al.
Published: (2024-03-01)

Metformin use and severe dengue in diabetic adults
by: Lye, David Chien, et al.
Published: (2018)

Comparing prophylactic effect of exercise and metformin on cognitive brain functions in rats with type 3 diabetes mellitus
by: Hader Ibrahim Sakr, et al.
Published: (2020-09-01)

Influence of metabolic stress and metformin on synaptic protein profile in SH‐SY5Y‐derived neurons
by: Alex J. T. Yang, et al.
Published: (2023-11-01)

Unraveling genetic causality between metformin and myocardial infarction on the basis of Mendelian randomization
by: Yongru Zhuang, et al.
Published: (2024-05-01)

Role of Metformin in Preventing New-Onset Chronic Kidney Disease in Patients with Type 2 Diabetes Mellitus
by: Yu-Ling Lin, et al.
Published: (2025-01-01)

Effect of metformin on the neuronal morphology of frontal cortex and hippocampal regions in lipopolysaccharide induced neuroinflammation in male Wistar rats
by: Vandana Blossom, et al.
Published: (2025-03-01)

The Association between Metformin Use and Risk of Developing Severe Dementia among AD Patients with Type 2 Diabetes
by: Ying Xue, et al.
Published: (2023-10-01)

Metformin Protects against Podocyte Injury in Diabetic Kidney Disease
by: Sanna Lehtonen
Published: (2020-12-01)

Dose–Response Association of Metformin with Parkinson’s Disease Odds in Type 2 Diabetes Mellitus
by: Kuang-Hua Huang, et al.
Published: (2022-04-01)

Investigation of Anti-inflammatory, Antioxidative, and Cardioprotective Effects of Combined Metformin and Exercise in Rats
by: Şerif Demir, et al.
Published: (2024-12-01)

The Role and Mechanism of Metformin in Inflammatory Diseases
by: Lin H, et al.
Published: (2023-11-01)